Agilent Technologies (A) Expected to Announce Quarterly Earnings on Wednesday

Key Points

• Agilent Technologies is set to announce its Q3 2025 earnings on August 27th, with expectations of $1.37 per share and $1.666 billion in revenue.
• The company reported a quarterly EPS of $1.31 in May, exceeding estimates, and experienced a 6.0% revenue increase compared to the previous year.
• Agilent's stock is currently trading at around $120, and analysts have an average target price of $139.77, reflecting a mostly positive outlook with several buy ratings.

Agilent Technologies (NYSE:A - Get Free Report) is projected to issue its Q3 2025 results after the market closes on Wednesday, August 27th. Analysts expect the company to announce earnings of $1.37 per share and revenue of $1.6660 billion for the quarter. Agilent Technologies has set its FY 2025 guidance at 5.540-5.610 EPS. Q3 2025 guidance at 1.350-1.370 EPS.Interested persons may review the information on the company's upcoming Q3 2025 earningreport for the latest details on the call scheduled for Wednesday, August 27, 2025 at 4:30 PM ET.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm's quarterly revenue was up 6.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.22 earnings per share. On average, analysts expect Agilent Technologies to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Agilent Technologies Price Performance

A traded up $4.3420 during midday trading on Friday, hitting $121.4920. 1,290,972 shares of the company traded hands, compared to its average volume of 1,284,543. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The company has a market capitalization of $34.51 billion, a price-to-earnings ratio of 30.00, a PEG ratio of 3.55 and a beta of 1.22. Agilent Technologies has a 52-week low of $96.43 and a 52-week high of $153.84. The business has a 50 day simple moving average of $117.88 and a two-hundred day simple moving average of $117.47.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Barclays raised their price target on shares of Agilent Technologies from $115.00 to $125.00 and gave the stock an "equal weight" rating in a research note on Tuesday, June 24th. Robert W. Baird dropped their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Evercore ISI lifted their price objective on shares of Agilent Technologies from $125.00 to $130.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, June 28th. Finally, TD Cowen lifted their price target on shares of Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Seven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $139.77.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the sale, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.26% of the company's stock.

Institutional Trading of Agilent Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. Brighton Jones LLC raised its position in Agilent Technologies by 6.1% in the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Diversify Advisory Services LLC acquired a new position in Agilent Technologies in the 2nd quarter valued at $670,000. Acadian Asset Management LLC increased its stake in Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock valued at $625,000 after buying an additional 758 shares during the period. Jones Financial Companies Lllp increased its stake in Agilent Technologies by 15.9% in the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after buying an additional 769 shares during the period. Finally, Brevan Howard Capital Management LP acquired a new position in Agilent Technologies in the 2nd quarter valued at $482,000. Hedge funds and other institutional investors own 87.41% of the company's stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.